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Loss of the Metalloprotease ADAM9
Leads to Cone-Rod Dystrophy in Humans
and Retinal Degeneration in Mice
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Cone-rod dystrophy (CRD) is an inherited progressive retinal dystrophy affecting the function of cone and rod photoreceptors. By
autozygosity mapping, we identiﬁed null mutations in the ADAM metallopeptidase domain 9 (ADAM9) gene in four consanguineous
families with recessively inherited early-onset CRD. We also found reduced photoreceptor responses in Adam9 knockout mice, previ-
ously reported to be asymptomatic. In 12-month-old knockout mice, photoreceptors appear normal, but the apical processes of the
retinal pigment epithelium (RPE) cells are disorganized and contact between photoreceptor outer segments (POSs) and the RPE apical
surface is compromised. In 20-month-old mice, there is clear evidence of progressive retinal degeneration with disorganized POS and
thinning of the outer nuclear layer (ONL) in addition to the anomaly at the POS-RPE junction. RPE basal deposits and macrophages
were also apparent in older mice. These ﬁndings therefore not only identify ADAM9 as a CRD gene but also identify a form of pathology
wherein retinal disease ﬁrst manifests at the POS-RPE junction.Cone-rod dystrophy (CRD [MIM #120970]) is a group of
genetically and phenotypically heterogenous retinal disor-
ders usually manifesting in childhood or early adulthood.
CRD is characterized by predominant or equal loss of cone
compared to rod photoreceptors, reduced visual acuity,
color-vision abnormalities, photophobia, and visual-ﬁeld
loss. To date, 11 genes and a further six loci have been asso-
ciated with CRD, which is most commonly inherited in an
autosomal-dominant manner (RetNet). So far, only
ABCA41–3 (MIM *601691) and RPGRIP14 (MIM þ605446)
mutations have been shown to cause nonsyndromic auto-
somal-recessive CRD, with two other published recessive
loci.5,6 Only RPGR (MIM *312610) mutations have been
associated with X-linked CRD.7,8
The CRD locus CORD9 on chromosome 8p11 was ﬁrst
identiﬁed in a consanguineous Brazilian family with child-
hood-onset visual-acuity impairment leading to major loss
of central and peripheral vision.5 Haplotype analysis re-
vealed a 12 Mb region with two putative homozygous
segments (5 and Figure 1A). To further reﬁne the locus,
we used autozygosity mapping, genotyping over 200 mi-
crosatellite markers and single-nucleotide polymorphisms
(SNPs) within the published locus in two affected individ-
uals (Table S1, available online). Known microsatellitemarkers and SNPs were selected from the UCSC genome
browser or the International HapMap project. Where
possible, SNPs with relatively high levels of heterozygosity
were chosen. Microsatellites were genotyped on an ABI
PRISM 377 DNA Sequencer and analyzed with Genscan
2.0.2 and Geno Typer 1.1.1 software (Applied Biosciences).
SNPs were analyzed by direct sequencing. The individuals
genotyped were from different sibships and are indicated
by arrows in Figure 2. These data provided support for
a 2.95 Mb homozygous segment between rs10955025
and rs725401 containing 34 genes (Figures 1B and 1C).
Candidate genes were chosen on the basis of known
expression in the vertebrate retina or eye, homology or
functional similarity to known retinal degeneration genes,
published studies indicating potential retinal function, and
published interactions with proteins thought to be impor-
tant for retinal function. We ampliﬁed genomic DNA by
PCR and sequenced ten genes within this region in affected
individuals (Figure 1). Sequencing revealed a homozygous
point mutation in the ADAM9 gene (MIM *602713),
altering the ﬁrst base of intron 11 (c.1130þ1G/A) and
abolishing the splice-site (Figure 2A). This mutation was
excluded in 190 ethnically matched control individuals
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Figure 1. Refinement of the CORD9 Locus
(A) Schematic of the CORD9 locus as defined by Danciger et al.5 The two published regions of homozygosity are shown shaded in black,
with the flanking heterozygous microsatellites marked on either side.
(B) Further genotyping of microsatellites and SNPs refined the region so that no block of homozygosity greater than 0.5 Mb remained in
the first region and the second region was refined to a 2.95 Mb area of homozygosity at the proximal end of the published interval.
(C) A representation of the refined CORD9 region showing 34 potential candidate genes. The following genes were sequenced in this
study: ADAM9 (MIM *602713), BAG4 (MIM *603884), DDHD2, FGFR1 (MIM *136350), GPR124 (MIM *606823), HTRA4 (MIM *610700),
PLEKHA2 (MIM *607773), RAB11FIP1 (MIM *608737), ERLIN2 (MIM *611605), and TM2D2 (MIM *610081).Further autozygositymappingwith10k and250kAffyme-
trix SNP arrays and microsatellite markers identiﬁed three
additional CORD9-linked families of Pakistani (MEP49),
Tunisian Jewish (MOL0172), and Arab Muslim (MOL0277)
origin. Each was consanguineous and showed a recessive
inheritance pattern. Affected individuals in these families
reported poor visual acuity in the ﬁrst decade of life, but
nystagmus and photophobia were not noted. Outer retinal
atrophy was observed in the macula. Most patients had
discrete white patches in the posterior pole and around the
optic disc with a pigmentary retinopathy, anterior to the
equator. Themidperipheral retina showedminimal changes
on clinical examinationof youngpatients. In older patients,
peripheral pigmentary changes could be observed in some
cases. As previously published,5 electroretinograms (ERGs)
showed a similar degree of rod and cone involvement. The
study of human subjects was performed after all individuals
provided informed consent. Approval was obtained from
the institutional review boards of the participating centers.684 The American Journal of Human Genetics 84, 683–691, May 15Direct sequencing ofADAM9 inMEP49 revealed a homo-
zygous point mutation in exon 9, creating a premature
stop codon (c.766C/T; p.R256X) (Figure 2A). A second
homozygous stop codon was identiﬁed in MOL0172
(c.490C/T; p.R164X) (Figure 2A). InMOL0277, a homozy-
gous intronic change (c.411-8A/G) was the only poten-
tially pathogenic change identiﬁed. Sequence of cDNA
derived from patients’ peripheral blood lymphocyte
mRNA demonstrated that this mutation activated a cryptic
splice acceptor site giving rise only to an aberrant tran-
script (Figure 2B). The mutant transcript has seven addi-
tional base pairs of sequence added to the beginning of
exon 6 and is predicted to introduce a frameshift resulting
in premature termination (R137SfsX16). Amplicons from
individuals heterozygous and homozygous for the
c.766C/T; p.Arg256X mutation were shown to have
distinct melting curves by high-resolution melting-curve
analysis (HRMCA) when compared to DNA without this
mutation (not shown). HRMCA of 138 ethnically matched, 2009
Figure 2. ADAM9 Mutations in CORD9 Patients
(A) Pedigrees of three of the CORD families with genomic DNA sequence of the ADAM9 mutations they carry. The two members of the
Brazilian CORD9 family genotyped for refinement of the locus are indicated by arrows. All mutations were shown to segregate with
the phenotype in each family by direct sequencing.
(B) Pedigree of MOL0277 with genomic and cDNA sequences from mRNA of an affected family member versus an unaffected control
individual. cDNA was generated by the Verso cDNA kit according to the manufacturer’s protocol. The following primers were designed
to amplify through exon 6: forward, GACCTTTTGCCTGAAGATTTTG (50–30 located within exon 4); reverse, TCCAAGTAGTTTGCCAGGAG (50–30
located within exon 8). The base change at position c.411-8 A/G. and the 7 bp insertion from the 30 end of intron 5 in the RNA transcript
are highlighted.The American Journal of Human Genetics 84, 683–691, May 15, 2009 685
Figure 3. Structure of ADAM9 and Molecular Consequences of CORD9 Mutations
(A) Exon-intron structure of the ADAM9 gene showing the positions of mutations in CORD9 patients.
(B) Domain structure of ADAM9 protein showing the transmembrane and soluble isoforms, with the locations of the CORD9 mutations
marked.control individuals conﬁrmed that this mutation was not
present in unaffected individuals. The c.490C/T;
p.R164X and c.411-8A/G mutations were excluded by
direct sequencing in 105 and 160 ethnically matched
control individuals, respectively.
Two of the human mutations are nonsense changes and
the remaining two appear to lead to nonsense changes
following splicing defects (Figure 3), strongly suggesting
that ADAM9 is likely to be absent in these patients because
of nonsense-mediated decay. In order to elucidate the
pathogenic mechanism, we therefore investigated previ-
ously generated mice that are null for the Adam9 gene
and show no major morphological, histopathological, or
behavioral abnormalities during development or early
adult life.9 We performed ERGs to assess the electrical
response of the retina to light in these mice. The rod
photoreceptor response of 12-month-old Adam9/ mice,
as measured by the dark-adapted a-wave,10 showed a satu-
rated response of approximately 50% the amplitude of
wild-type mice (Figures 4A and 4C, Table 1). Twenty-
month-old Adam9/mice had saturated a-wave responses
approximately 30% the amplitude of the age-matched
wild-type (Figures 4B and 4C, Table 1), suggesting a progres-
sive retinal degeneration. Rod b-waves, reﬂecting the depo-
larizing response of rod bipolar cells, were less severely but
signiﬁcantly reduced in Adam9/ mice (Figure 4, Table 1).
Although reductions of cone-driven b-wave responses were
not statistically signiﬁcant in 12-month-old mice, prob-
ably because of the low proportion of cone photoreceptors
in the mouse retina, 20-month-old mice had proportion-
ally greater reductions compared to age-matched wild-
types, with statistically signiﬁcant Student’s t test p values
(Figure 4C, Table 1). These data suggest a progressive
degeneration affecting both rods and cones in Adam9/
mice.
Histological analysis of retinas from 12-month-old
Adam9/ mice showed an abnormal gap between the686 The American Journal of Human Genetics 84, 683–691, May 15POS and RPE (Figure 5B). Electron microscopy revealed
extended malformed, vesiculated RPE apical processes
(Figures 5E and 5F) and disrupted contact with the POS.
However, photoreceptors and other neuronal layers
appeared structurally normal at this age. Analysis of
20-month-old Adam9/ mice provided evidence for
further degeneration. In addition to the POS-RPE interface
abnormalities observed at 12 months, these mice had
disorganized POS and a thinning outer nuclear layer
(ONL) (Figure 5D), macrophages within the gap between
the POS and the RPE (Figure 5L), and unusual infoldings
of the basal membrane of the RPE (Figure 5J). In some
slides, material could also be seen deposited between the
RPE and Bruch’s membrane (Figure 5K). These histological
ﬁndings reveal a progressive degeneration consistent with
ERG analyses and implicate the POS-RPE junction as the
site at which the pathology ﬁrst manifests. A defect in
the extracellular matrix (ECM) between the POS and the
RPE may be responsible for the initial defects in photore-
ceptor signaling detected by ERGs, in a similar manner to
that which has been suggested by analysis of Slc16a8/
mice.11 It is intriguing to speculate that the basal deposits
observed (Figure 5K) may be analogous to the drusen
deposits observed in human retinal degenerations, such
as CRD and age-related macular degeneration (AMD). It
is also interesting to note that macrophages have been
implicated in the pathology of AMD.
We performed immunoﬂuorescence on mouse retinas to
establish Adam9 expression in the eye. Although we
observed the brightest Adam9 staining at the apical surface
of the RPE (Figure S1), the site of observed pathology in
mice, staining of some sections from Adam9/ mice indi-
cated cross-reactivity at the same site. These data should
therefore be interpreted with caution.
ADAM9 is a widely expressed and particularly polyvalent
member of the multifunctional ADAM family of proteins.
It has been implicated in cell-matrix interactions,12 ECM, 2009
Figure 4. Adam9/ Mice Have
Reduced Photoreceptor Responses
Compared to Age-Matched Wild-Type
Mice
Electroretinography was performed as
described previously10,41 on mice dark
adapted for a minimum of 12 hr with pupils
dilated with 1% Tropicamide. Full-field
ERGs were recorded in a Ganzfeld dome
on dark-adapted, anesthetized mice, with
caution taken to maintain 37C body
temperature at all times.
(A) Representative scotopic ERG traces
following ~1ms light-flash stimulus that
isomerized about 1% of the rhodopsin in
the rods from 12-month-old mice with
stimulus applied at time ¼ 0.
(B) Representative scotopic ERG traces
from 20-month-old mice with stimulus
applied at time ¼ 0.
(C) Average scotopic rod a-wave and
b-wave amplitudes of 12-month-old and
20-month-old wild-type and Adam9/
mice plus photopic cone b-wave ampli-
tudes. Six wild-type and seven Adam9/
12-month-old mice were used in the anal-
ysis, and two wild-type and three
Adam9/ mice were available for the
20 month analysis. Twelve-month-old
Adam9/ mice had an average a-wave
value of approximately 50% compared to
age-matched wild-type decreasing to only
30% of age-matched wild-type mice in
20-month-old mice (p < 0.05, Student’s
t test). Reduction of rod b-wave amplitudes were also significant in 12-month-old knockout mice (p < 0.05, Student’s t test), but
b-wave data from 20-month-old mice were not statistically significant, probably because of the low number of older mice available to
study and the proportionally lesser drop in b-wave response, which was also observed in the 12-month-old mice. Cone b-waves were
approximately 75% of wild-type in 12-month-old Adam9/ mice decreasing to 49% in 20-month-old mice, with statistically significant
changes (p< 0.05, Student’s t test) in the 20-month-old mice. Error bars represent standard error of the mean. See Table 1 for a summary
of ERG data.remodeling,13 alpha-secretase activity for amyloid
precursor protein (APP),14 HB-EGF shedding,15 and the
pathology of cancer16–18 and Alzheimer disease,14 but until
now a physiological role remained elusive. It has been sug-
gested previously that absence of an ortholog inDrosophila
melanogaster and Caenorhabditis elegans may indicate that
ADAM9 functions in cells or organs that are more highly
evolved in vertebrates,9 and our data support the ideathat ADAM9 fulﬁlls a speciﬁc role in the vertebrate retina.
Whereas dysregulation of members of the ADAM family
has been implicated in the pathogenesis of diseases such
as Alzheimer, cancer, rheumatoid arthritis, and asthma
(reviewed in 19), and ADAM9 has been shown to be down-
regulated in cataracts,20 to the best of our knowledge no
other germinal mutation in an ADAM has been shown to
be the direct cause of disease.Table 1. Summary of ERG Data
12 Month 20 Month
Adam9þ/þ Adam9/ t Test Adam9þ/þ Adam9/ t Test
Rod a-wave (mV) 4055 35 2105 12 0.0059 1675 48 48 5 6 0.0457
Rod b-wave (mV) 4925 41 3515 31 0.0304 2065 46 1605 18 0.6067
Cone b-wave (mV) 2285 33 1725 14 0.2141 1635 6 80 5 4 0.03515
Average amplitudes of rod a-waves, rod b-waves, and cone b-waves 5 standard error (SE) are shown for each age group and genotype. Student’s t test
p values indicate statistical significance.
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Figure 5. Physical Abnormalities of the Adam9/ Retina
Eye cups from three knockout and three wild-type mice of each age were fixed in 2% paraformaldehyde þ 2% glutaraldehyde in 0.2 M
sodium cacodylate buffer (pH 7.4) for 4 hr before being trimmed and postfixed in 1% osmium tetroxide. Tissues were dehydrated in
a graded ethanol series, infiltrated, and embedded in Epon resin (EMbed812; Electron Microscopy Sciences) according to the manufac-
turer’s instructions.
(A–D) Sections of 1 mm thickness were cut and stained with alkaline toluidine blue for light microscopy. Twelve-month-old wild-type
retinas (A) and 20-month-old wild-type retinas (C) show normal retinal structure with a tight interface between the POS and RPE
(indicated by arrows). (B) Twelve-month-old Adam9/ mice show otherwise normal retinal histology except for an abnormal gap
between the POS and RPE, indicated by an arrow. (D) Twenty-month-old Adam9/ mice had the same abnormal interface but also
displayed disorganized POS and thinning ONL, indicative of degeneration.
(E–L) Ultrathin sections of 60 to 80 nm thickness were cut, stained with lead citrate and uranyl acetate, and examined with a Tecnai
transmission electron microscope. Electron microscopy shows (E) normal POS-RPE interfaces in 12-month-old wild-type retinas compared
with (F) abnormal interfaces between the POS and RPE (arrow) in 12-month-old Adam9/ retinas. Comparison of 12-month-old (G) wild-
type and (H) Adam9/ POS and IS showed that the photoreceptors appeared structurally normal. (I) Twenty-month-old wild-type retinas
show normal morphology. (J) In addition to abnormal POS-RPE interfaces, the basal surface of the RPE shows abnormal infoldings (arrow)
in 20-month-old Adam9/ eyes. (K) In some 20-month-old Adam9/ sections, electron-dense deposits between BM and the RPE were
observed (arrow). Disorganized photoreceptor outer segments are visible in addition to the abnormal OS-RPE interface. (L) Tissue macro-
phages (arrow) were observed in 20-month-old Adam9/ retinas.
The following abbreviations are used: ONL, outer nuclear layer; POS, photoreceptor outer segments; IS, photoreceptor inner segments;
RPE, retinal pigment epithilium; and BM, Bruch’s membrane.Our ﬁndings could suggest a defect in adhesion at the
POS-RPE interface in the absence of Adam9. Indeed,
Adam9 has been shown to function as an adhesion mole-
cule by binding to avb5 integrin.
21 avb5 integrin, the only
integrin localized to the apical surface of the RPE,22,23 is
required for retinal adhesion24 and phagocytosis of
POS.23 In addition, integrin b5
/ mice have age-related
vision loss.25 Adam9 at the POS-RPE junction could there-
fore interact with avb5 integrin and may mediate adhesion
of POS to the RPE and efﬁcient uptake of shed outer
segments. However, ERGs in the Adam9/ mice appear
less severely disturbed than those of b5
/ mice, whereas
b5
/ mice lack the morphological abnormalities observed
at the RPE-POS junction in Adam9/ mice. This suggests
that Adam9 has an additional role in the retina indepen-688 The American Journal of Human Genetics 84, 683–691, May 15dent of avb5 integrin, possibly in the remodeling of the
ECM between the RPE and POS or in the shedding of
factors essential for the maintenance of the ECM.
Interestingly, genes adjacent to ADAM9 on chromosome
8 (Figure 1C) display a degree of paralogy with the locus on
chromosome 10 implicated in AMD,26,27 the functional
variant of which is still debated.28–32 The TACC2 (MIM
*605302), PLEKHA1 (MIM *607772), and HTRA1 (MIM
*602194) genes at the AMD-associated locus on chromo-
some 10 have paralogs in the form of the TACC1 (MIM
*605301), PLEKHA2 (MIM *607773), and HTRA4 (MIM
*610700) genes adjacent to ADAM9 at the CORD9 locus
on chromosome 8. However, there is no ADAM family
member at the AMD locus on chromosome 10. Neverthe-
less, the fact that these genes lie in the same orientation, 2009
relative to each other at each locus and that ADAM9 is the
next-but-one gene in the same orientation raises an
intriguing if speculative possibility that a shared regulatory
element for these loci may inﬂuence the transcription of
ADAM933.
Several components of the ECMhave been implicated in
AMD or AMD-related disorders.31,34–37 Mice with a homo-
zygous mutation in one of these, TIMP3 (MIM *188826),
encoding an inhibitor of metalloproteases, appear to
show disturbances of the apical processes of the RPE in
addition to basal infoldings, similar to the changes
observed in Adam9/ mice.38 Although ADAM9 is
thought not to be inhibited by TIMP3,39 our data suggest
that it may be worthwhile to re-evaluate the possibility
of an interaction between these molecules. Furthermore,
drusen deposits from cases of AMD have been shown to
contain amyloid beta40 and some Adam9/ mice appear
to have drusen-like deposits, so it is tempting to consider
that loss of ADAM9, a protease with alpha-secretase
activity potentially contributing to the nonamyloidogenic
pathway of APP processing, could result in an increase in
amyloid beta production. Further analysis of basal deposits
in the Adam9/ retina will be required to test this theory.
In summary,wehavedemonstrated apathology localized
to the POS-RPE junction and leading to retinal degenera-
tion in Adam9/mice and shown that ADAM9mutations
cause retinal degeneration in human patients. The milder
phenotype of Adam9/mice is likely to represent the early
stages of the human disease because of a combination of
shorter life span, the progressive nature of CORD, and the
fact that mice lack a macula, instead showing uniform
photoreceptor density. Indeed, the comparatively mild
mouse phenotype suggests that the most important func-
tion of ADAM9 may be in areas of high photoreceptor
density or associated with cones. Whereas several mouse
models have exhibited varying forms of retinal degenera-
tion wherein the photoreceptors are not the initial site of
pathology, to the best of our knowledge the Adam9/
phenotype is unique and no human disease has been previ-
ously linked to such a phenotype. Our data therefore
uncover a physiological role for ADAM9, reveal what we
believemaybe anovel causative pathway for human retinal
degeneration, and highlight a potentially overlooked path-
ological feature of retinal degenerations, including CRD
and AMD. Finally, the observation that photoreceptors
appear to be intact in the early stages of the disease also
suggests thatADAM9maybe a valid target for gene therapy.
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